NASDAQ
Creso Pharma Limited (COPHF) has a free cash flow growth of 129.37% as of Friday, May 29, 2026. This represents a 1283.61% increase compared to its 12-month average of 9.35%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.